Vitamin d derivative may help keep bones strong after menopause
NCT ID NCT07660536
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This trial investigates whether doxercalciferol, a form of vitamin D, can prevent bone loss in the spine and thigh bone in postmenopausal women with low bone density. Participants take either doxercalciferol or a placebo daily for two years, with bone density measured at the start, 12 months, and 24 months. The goal is to see if this drug can help maintain bone strength and reduce fracture risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
doxercalciferol
What this could lead to
If it works, this could point toward a non-hormonal option to slow bone loss and reduce fracture risk in postmenopausal women.
What could go wrong
This is a small, early-to-mid-stage trial. The drug may not improve bone density more than placebo, and side effects like elevated calcium levels are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS (SENILE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Creighton University Medical center
Omaha, Nebraska, 68132, United States